AlphaYouKH
Schedule 13D filing
KI Holdings, Ltd. disclosed a 10.2% stake in Hepion Pharmaceuticals, Inc. (HEPA)
KI Holdings, Ltd. reported owning 10.2% of Hepion Pharmaceuticals, Inc. (HEPA) (10,000,000 shares) in a Schedule 13D filed Sep 16, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 16, 2026
- Source
- Schedule 13D
More HEPA insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.